References

1. World Health Organization 2011/2012 (2011) Tuberculosis Global Facts Geneva: World Health Organization [View]
2. Styers D, Sheehan DJ, Hogan P, Sahm DF (2006) Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 5: 2 [CrossRef] [Google Scholar] [PubMed]
3. Borg MA, de Kraker M, Scicluna E, et al. (2007) Prevalence of methicillinresistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 60: 1310- 1315 [CrossRef] [Google Scholar] [PubMed]
4. Appelbaum PC (2012) 2012 and Beyond: Potential for the Start of a Second Pre-antibiotic Era? J Antimicrob Chemother 67: 2062-2068 [CrossRef] [Google Scholar] [PubMed]
5. Center for Disease Control and Prevention World Health Day: Media Fact Sheet
6. Center for Disease Control and Prevention (2013) Antibiotic Resistance Threats in the United States [View]
7. European Medicine Agency The bacterial challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents [View]
8. Walsh C (2003) Antibiotics: Actions, Origins, Resistance. American Society for Microbiology (ASM) Press; Washington, DC [CrossRef] [Google Scholar] [PubMed]
9. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal Carriage of Staphylococcus aureus: Epidemiology, Underlying Mechanisms, and Associated Risks. Clin Microbiol Rev 10: 505-520 [Google Scholar] [PubMed]
10. Antibiotic/Antimicrobial Resistance (2013) Center for Disease Control and Prevention (CDC) report
11. Huang H, Flynn NM, King JH, Monchaud C, Morita M, et al. (2006) Comparisons of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Hospital-Associated MSRA Infections in Sacramento, California. J Clin Microbiol 44: 2423-2427 [CrossRef] [Google Scholar] [PubMed]
12. Pires NR, Cunha PLR, Maciel JS, Angelim AL, Melo VMM, et al. (2006) Sulfated chitosan as tear substitute with no antimicrobial activity. Carbohydr Polym 91: 92-99 [CrossRef] [Google Scholar] [PubMed]
13. Madhumathi K, Kumar PTS, Abhilash S, Sreeja V, Tamura H, et al. (2010) Development of novel chitin/nanosilver composite scaffolds for wound dressing applications. J Mater Sci Mater Med 21: 807-813 [CrossRef] [Google Scholar] [PubMed]
14. Jayakumar R, Menon D, Manzoor K, Nair SV, Tamura H (2010) Biomedical applications of chitin and chitosan based nanomaterials-A short review. Carbohydr Polym 82: 227-232 [CrossRef] [Google Scholar]
15. Allan CR, Hardwiger LA (1979) The fungicidal effect of chitosan on fungi of varying cell wall composition Experimental Mycology 3: 285-287 [CrossRef] [Google Scholar]
16. Hirano S, Nagao N (1989) Effects of chitosan, pectic acid, lysozyme, and chitinase on the growth of several phytopathogens. Agricultural and Biological Chemistry 53: 3065-3066 [CrossRef] [Google Scholar]
17. Kendra DF, Hadwiser LA (1984) Characterization of the smallest chitosan oligomer that is maximally antifungal to Fusariumsolani and elicits pisatin formation in Pisumsativum. Exp Mycol 8: 276-281 [CrossRef] [Google Scholar]
18. Uchida Y, Izume M, Ohtakara A, Skjak-Braek G, Anthonsen T, et al. (Eds.), Chitin and chitosan, Elsevier, London, UK, pp. 373
19. Ueno K, Yamaguchi T, Sakairi N, Nishi N, Tokura S, et al. (Eds.), Advances in chitin science, Jacques Andre, Lyon (1997), p. 156
20. Kittur F, Kumar K andTharanathan RZ (1998) Functional packaging properties of chitosan films Lebensm Unters Forsch 206: 44-47 [Google Scholar]
21. Brown MRW, Richards RME (1965) Effect of ethylene diaminetetracetate on the resistance of Pseudomonas aeruginosa to antibacterial agents. Nature 207: 1391-1393 [CrossRef] [Google Scholar] [PubMed]
22. Lambert RJ, Hanlon GW, Denyer SP (2004) The synergistic effect of EDTA/ antimicrobial combinations on Pseudomonas aeruginosa. J Appl Microbiol 96: 244-253 [CrossRef] [Google Scholar] [PubMed]
23. Sheikh MA, Parker MS (1972) The influence of ethylenediaminetetraacetic acid and phenylethanol upon the fungistatic action of aminacrine hydrochloride. Journal of Pharmacy and Pharmacology 24:118
24. Hart JR (1984) Chelating agents as preservative potentiators. In: Cosmetic and Drug Preservation: Principles and Practice ed. Kabara, Marcell Dekker JJ, New York, pp. 323-337
25. Vaara M (1992) Agents that increase the permeability of the outer membrane. Microbiological Reviews 56: 395-411 [Google Scholar] [PubMed]
26. Weiser R, Asscher AW, Wimpenny J (1968) In vitro reversal of antibiotic resistance by ethylenediamine tetraacetic acid. Nature 219: 1365-1366 [CrossRef] [Google Scholar] [PubMed]
27. Larson JE, Morrow SL, Happel L, Sharp JF, Cohen JC (1997) Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 349: 619-620 [CrossRef] [Google Scholar] [PubMed]
28. Sharma M, Visai L, Bragheri F, Cristiani I, Gupta PK, et al. (2008) Toluidine blue- mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother 52: 299-305 [CrossRef] [Google Scholar]
29. Raad I, Hanna H, Dvorak T, Chaiban G and Hachem R (2007) Optimal antimicrobial catheter lock solution using different combinations of minocycline, EDTA, and 25 percent ethanol rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51: 78-83 [CrossRef] [Google Scholar] [PubMed]
30. Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48: 5-16 [CrossRef] [Google Scholar] [PubMed]
31. Eliopoulos GM, Eliopoulos CT (1988) Antibiotic combinations: should they be tested? Clin Microbiol Rev 1: 139-156 [CrossRef] [Google Scholar] [PubMed]
32. Eliopoulos GM, Moellering RC (1996) Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th ed.; Lorain, V., Ed.; The Williams & Wilkins Co.: Baltimore, MD, USA, pp. 330-396
33. Cruishank R, Duguid JP, Marmion BP, Swain RHA (1975) Medical Microbiology. The Practice of Medical Microbiology, 12th ed.; Churchill Livingstone: London, UK
34. Kahkeshani N, Farahanikia B, Mahdaviani P, Abdolghaffari A, Hassanzadeh G, et al. (2013) Antioxidant and burn healing potential of Galiumodoratum extracts. Res Pharma Sci 8: 197-203 [Google Scholar] [PubMed]
35. Papineau AM, Hoover DG, Knorr D, Farkas DF (1991) Antimicrobial effect of water-soluble chitosans with high hydrostatic pressure. Food Biotechnol 5: 45-57 [CrossRef] [Google Scholar]
36. Sudarshan NR, Hoover DG, Knorr D (1992) Antibacterial action of chitosan. Food Biotechnol 6: 257-272 [CrossRef] [Google Scholar]
37. Lim SH, Hudson SM (2004) Synthesis and antimicrobial activity of a watersoluble chitosan derivative with a fiber-reactive group. Carbohydr Res 339: 313-319 [CrossRef] [Google Scholar] [PubMed]
38. AzizMA, CabralJD, BrooksHJL, MorattiSC, Hanton LR (2012) Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use. Antimicrob Agents Chemother 56: 280-287 [CrossRef] [Google Scholar] [PubMed]
39. LecetaI, GuerreroP, IbarburuI, DueñasMT, de la CabaK (2013) Characterization and antimicrobial analysis of chitosan-based films. J Food Eng 116: 889-899 [CrossRef] [Google Scholar]
40. El-Sharif AA and HussainMHM (2011) Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections. Curr Microbiol 62: 739-745 [CrossRef] [Google Scholar] [PubMed]
41. Qi LF, Xu ZR, Jiang X, Hu CH, Zou XF (2004) Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339: 2693-2700 [CrossRef] [Google Scholar] [PubMed]
42. Liu H, Du YM, Wang XH, Sun LP (2004) Chitosan kills bacteria through cell membrane damage. Int J Food Microbiol 95: 147-155 [CrossRef] [Google Scholar] [PubMed]
43. Kong M, Chen XG, Xing K, Park HJ (2010) Antimicrobial properties of chitosan and mode of action: A state of the art review. Int J Food Microbiol 144: 51-63 [CrossRef] [Google Scholar] [PubMed]
44. Raafat D, Von Bargen K, Haas A, Sahl H-G (2008) Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol 74: 3764-3773 [CrossRef] [Google Scholar] [PubMed]
45. Raafat D, Sahl HG (2009) Chitosan and its antimicrobial potential-a critical literature survey. Microbial Biotechnology 2: 186-201 [CrossRef] [Google Scholar] [PubMed]
46. Tsai GJ, Su WH (1999) Antibacterial activity of shrimp chitosan against Escherichia coli. J Food Prot 62: 239-243 [CrossRef] [Google Scholar] [PubMed]
47. Jumaa M, Furkert FH, Muller BW (2002) A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur J Pharm Biopharm 53: 115-123 [CrossRef] [Google Scholar] [PubMed]
48. No HK, Park NY, Lee SH, Meyers SP (2002) Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int J Food Microbiol 74: 65-72 [CrossRef] [Google Scholar]
49. El-Sharif AA, Hussain MH (2011) Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections. Curr Microbiol 62: 739-745 [CrossRef] [Google Scholar] [PubMed]